|
1
|
Eichler W: Characteristics of two
CD75-related cell-surface expressed antigens of human lymphocytes.
Mol Immunol. 44:2047–2055. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carbone A and Gloghini A: CD75: A B-cell
marker which should not be forgotten in lymphocyte predominant
Hodgkin lymphoma. Am J Hematol. 89:4492014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Harduin-Lepers A, Vallejo-Ruiz V,
Krzewinski-Recchi MA, Samyn-Petit B, Julien S and Delannoy P: The
human sialyltransferase family. Biochimie. 83:727–737. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dall'Olio F: The
sialyl-alpha2,6-lactosaminyl structure: Biosynthesis and functional
role. Glycoconj J. 17:669–676. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nitschke L: The role of CD22 and other
inhibitory co-receptors in B-cell activation. Curr Opin Immunol.
17:290–297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stamenkovic I, Sgroi D, Aruffo A, Sy MS
and Anderson T: The B-lymphocyte adhesion molecule CD22 interacts
with leukocyte common antigen CD45RO on T cells and alpha 2–6
sialyltransferase, CD75, on B cells. Cell. 66:1133–1144. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sgroi D, Varki A, Braesch-Andersen S and
Stamenkovic I: CD22, a B cell-specific immunoglobulin superfamily
member, is a sialic acid-binding lectin. J Biol Chem.
268:7011–7018. 1993.PubMed/NCBI
|
|
8
|
Hennet T, Chui D, Paulson J and Marth JD:
Immune regulation by the ST6Gal sialyltransferase. Proc Natl Acad
Sci USA. 95:pp. 4504–4509. 1998; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dorken B, Moller P, Pezzutto A,
Schwartz-Albiez R and Moldenhauer G: B-cell antigens:
CDw75Leukocyte Typing IV. White Cell Differentiation Antigens.
Knapp W, Dorken B, Gilks WR, Rieber EP, Schmidt RE, Stein H and von
den Borne AEPGK: Oxford University Press; Oxford: pp. 109–110.
1989
|
|
10
|
Reed W, Erikstein BK, Funderud S, Lilleng
R, Tvedt K and Nesland JM: CDw75 antigen expression in breast
lesions. Path Res Pract. 189:394–398. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shen L, Li HX, Luo HS, Shen ZX, Tan SY,
Guo J and Sun J: CDw75 is a significant histopathological marker
for gastric carcinoma. World J Gastroenterol. 10:1682–1685. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Distler U, Souady J, Hülsewig M,
Drmić-Hofman I, Haier J, Denz A, Grützmann R, Pilarsky C, Senninger
N, Dreisewerd K, et al: Tumor associated CD75s and
CD75s-gangliosides are potential targets for adjuvant therapy in
pancreatic cancer. Mol Cancer Ther. 7:2464–2475. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dall'Olio F, Malagolini N, Di Stefano G,
Ciambella M and Serafini-Cessi F: Alpha 2,6 sialylation of
N-acetyllactosaminic sequences in human colorectal cancer cell
lines. Relationship with non-adherent growth. Int J Cancer.
47:291–297. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu Y, Srivatana U, Ullah A, Gagneja H,
Berenson CS and Lance P: Suppression of a sialyltransferase by
antisense DNA reduces invasiveness of human colon cancer cells in
vitro. Biochim Biophys Acta. 1536:148–160. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chiricolo M, Malagolini N, Bonfiglioli S
and Dall'Olio F: Phenotypic changes induced by expression of
beta-galactoside alpha2,6 sialyltransferase I in the human colon
cancer cell line SW948. Glycobiology. 16:146–154. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Swindall AF, Londoño-Joshi AI, Schultz MJ,
Fineberg N, Buchsbaum DJ and Bellis SL: ST6Gal-I protein expression
is upregulated in human epithelial tumors and correlates with stem
cell markers in normal tissues and colon cancer cell lines. Cancer
Res. 73:2368–2378. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Swindall AF and Bellis SL: Sialylation of
the Fas death receptor by ST6Gal-I provides protection against
Fas-mediated apoptosis in colon carcinoma cells. J Biol Chem.
286:22982–22990. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dall'Olio F, Malagolini N, di Stefano G,
Minni F, Marrano D and Serafini-Cessi F: Increased CMP-NeuAc: Gal
beta 1,4GlcNAc-R alpha 2,6 sialyltransferase activity in human
colorectal cancer tissues. Int J Cancer. 44:434–439. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Vázquez-Martín C, Gil-Martín E and
Fernández-Briera A: Elevation of ST6Gal I activity in malignant and
transitional tissue in human colorectal cancer. Oncology.
69:436–444. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gessner P, Riedl S, Quentmaier A and
Kemmner W: Enhanced activity of CMP-neuAc: Gal beta 1-4GlcNAc:alpha
2,6-sialyltransferase in metastasizing human colorectal tumor
tissue and serum of tumor patients. Cancer Lett. 75:143–149. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Elpek GO, Gelen T, Karpuzoğlu G,
Karpuzoğlu T, Aksoy NH and Keles N: Clinicopathologic evaluation of
CDw75 antigen expression in colorectal adenocarcinomas. Pathol
Oncol Res. 8:175–182. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Costa-Nogueira C, Villar-Portela S, Cuevas
E, Gil-Martín E and Fernández-Briera A: Synthesis and expression of
CDw75 antigen in human colorectal cancer. BMC Cancer. 9:4312009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Villar-Portela S, Muinelo-Romay L, Cuevas
E, Gil-Martín E and Fernández-Briera A: Disease-free survival of
colorectal cancer patients in relation to CDw75 antigen expression.
Pathobiology. 78:201–209. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lopez LC, Maillet CM, Oleszkowicz K and
Shur BD: Cell surface and Golgi pools of
beta-1,4-galactosyltransferase are differentially regulated during
embryonal carcinoma cell differentiation. Mol Cell Biol.
9:2370–2377. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smets LA and Van Beek WP: Carbohydrates of
the tumour cell surface. Biochim Biophys Acta. 738:237–249.
1984.PubMed/NCBI
|
|
26
|
Ramagli LS and Rodriguez L: Quantitation
of microgram amounts of protein in two-dimensional polyacrylamide
gel electrophoresis sample buffer. Electrophoresis. 6:559–563.
1985. View Article : Google Scholar
|
|
27
|
Rappsilber J, Ryder U, Lamond AI and Mann
M: Large-scale proteomic analysis of the human spliceosome. Genome
Res. 12:1231–1245. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang X and Zheng PS: Expression and
significance of CK7 and CK19 in colon cancer. Xi Bao Yu Fen Zi Mian
Yi Xue Za Zhi. 26:157–158. 2010.(In Chinese). PubMed/NCBI
|
|
29
|
Wu C, Jin X, Tsueng G, Afrasiabi C and Su
AI: BioGPS: Building your own mash-up of gene annotations and
expression profiles. Nucl Acids Res. 44:D313–D316. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
DiGiacomo V and Meruelo D: Looking into
laminin receptor: Critical discussion regarding the non-integrin
37/67-kDa laminin receptor/RPSA protein. Biol Rev Camb Philos Soc.
91:288–310. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang YJ, Chen WY, Huang CY, Liu HH and
Wei PL: Glucose-regulated protein 78 (GRP78) regulates colon cancer
metastasis through EMT biomarkers and the NRF-2/HO-1 pathway. Tumor
Biol. 36:1859–1869. 2015. View Article : Google Scholar
|
|
32
|
Black JD and Rezvani K: Heat shock protein
70s as potential molecular targets for colon cancer therapeutics.
Curr Med Chem. 23:3171–3188. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chang Y, Wu Y, Liu W and Ji G: Knockdown
of ERp44 leads to apoptosis via activation of ER stress in HeLa
cells. Biochem Biophys Res Commun. 463:606–611. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Weber J and Senior AE: ATP synthesis
driven by proton transport in F1F0-ATP synthase. FEBS Lett.
545:61–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mitchell P: Protonmotive redox mechanism
of the cytochrome b-c1 complex in the respiratory chain:
Protonmotive ubiquinone cycle. FEBS Lett. 56:1–6. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hong S and Pedersen PL: ATP synthase and
the actions of inhibitors utilized to study its roles in human
health, disease, and other scientific areas. Microbiol Mol Biol
Rev. 72:590–641. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xia D, Esser L, Tang WK, Zhou F, Zhou Y,
Yu L and Yu CA: Structural analysis of cytochrome bc1 complexes:
Implications to the mechanism of function. Biochim Biophys Acta.
1827:1278–1294. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Moll R, Divo M and Langbein L: The human
keratins: Biology and pathology. Histochem Cell Biol. 129:705–733.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Fuchs E and Cleveland DW: A structural
scaffolding of intermediate filaments in health and disease.
Science. 279:514–519. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chou CF, Smith AJ and Omary MB:
Characterization and dynamics of O-linked glycosylation of human
cytokeratin 8 and 18. J Biol Chem. 267:3901–3906. 1992.PubMed/NCBI
|
|
41
|
Giblett ER: The haptoglobin system. Ser
Haematol. 1:3–2012. 1968.
|
|
42
|
Uhlén M, Björling E, Agaton C, Szigyarto
CA, Amini B, Andersen E, Andersson AC, Angelidou P, Asplund A,
Asplund C, et al: A human protein atlas for normal and cancer
tissues based on antibody proteomics. Mol Cell Proteomics.
4:1920–1932. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Harvey S, Kohga S, Sait SN, Markus G, Hurd
TC, Martinick M, Geradts J, Saxena R and Gibbs JF: Co-expression of
urokinase with haptoglobin in human carcinomas. J Surg Res.
152:189–197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nakano M, Nakagawa T, Ito T, Kitada T,
Hijoka T, Kasahara A, Tajiri M, Wada Y, Taniguchi N and Miyoshi E:
Site-specific analysis of N-glycans on haptoglobin in sera of
patients with pancreatic cancer: A novel approach for the
development of tumor markers. Int J Cancer. 122:2301–2309. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Okuyama N, Ide Y, Nakano M, Nakagawa T,
Yamanaka K, Moriwaki K, Murata K, Ohigashi H, Yokoyama S, Eguchi H,
et al: Fucosylated haptoglobin is a novel marker for pancreatic
cancer: A detailed analysis of the oligosaccharide structure and a
possible mechanism for fucosylation. Int J Cancer. 118:2803–2808.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Park SY, Yoon SJ, Jeong YT, Kim JM, Kim
JY, Bernert B, Ullman T, Itzkowitz SH, Kim JH and Hakomori SI:
N-glycosylation status of beta-haptoglobin in sera of patients with
colon cancer, chronic inflammatory diseases and normal subjects.
Int J Cancer. 126:142–155. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Majumdar D, Tiernan JP, Lobo AJ, Evans CA
and Corfe BM: Keratins in colorectal epithelial function and
disease. Int J Exp Pathol. 93:305–318. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Modjtahedi N, Frebourg T, Fossar N,
Lavialle C, Cremisi C and Brison O: Increased expression of
cytokeratin and ferritin-H genes in tumorigenic clones of the SW
613-S human colon carcinoma cell line. Exp Cell Res. 201:74–82.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Mouat MF, Kolli K, Orlando R, Hargrove JL
and Grider A: The effects of quercetin on SW480 human colon
carcinoma cells: A proteomic study. Nutr J. 4:112005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Knösel T, Emde V, Schlüns K, Schlag PM,
Dietel M and Petersen I: Cytokeratin profiles identify diagnostic
signatures in colorectal cancer using multiplex analysis of tissue
microarrays. Cell Oncol. 28:167–175. 2006.PubMed/NCBI
|
|
51
|
Polley AC, Mulholland F, Pin C, Williams
EA, Bradburn DM, Mills SJ, Mathers JC and Johnson IT: Proteomic
analysis reveals field-wide changes in protein expression in the
morphologically normal mucosa of patients with colorectal
neoplasia. Cancer Res. 66:6553–6562. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Koelink PJ, Sier CF, Hommes DW, Lamers CB
and Verspaget HW: Clinical significance of stromal apoptosis in
colorectal cancer. Br J Cancer. 101:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Godfroid E, Geuskens M, Dupressoir T,
Parent I and Szpirer C: Cytokeratins are exposed on the outer
surface of established human mammary carcinoma cells. J Cell Sci.
99:595–607. 1991.PubMed/NCBI
|
|
54
|
Wells MJ, Hatton MW, Hewlett B, Podor TJ,
Sheffield WP and Blajchman MA: Cytokeratin 18 is expressed on the
hepatocyte plasma membrane surface and interacts with
thrombin-antithrombin complexes. J Biol Chem. 272:28574–28581.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Gires O, Andratschke M, Schmitt B, Mack B
and Schaffrik M: Cytokeratin 8 associates with the external leaflet
of plasma membranes in tumor cells. Biochem Biophys Res Commun.
328:1154–1162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hart GW, Haltiwanger RS, Holt GD and Kelly
WG: Glycosylation in the nucleus and cytoplasm. Annu Rev Biochem.
58:841–874. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Greis KD and Hart GW: Nuclear and
cytoplasmic glycoproteinsGlycoproteins II. Montreuil J,
Vliegenthart JFG and Schachter H: Elsevier Science; Amsterdam: pp.
33–51. 1997, View Article : Google Scholar
|
|
58
|
Lee HS, Qi Y and Im W: Effects of
N-glycosylation on protein conformation and dynamics: Protein Data
Bank analysis and molecular dynamics simulation study. Sci Rep.
5:89262015. View Article : Google Scholar : PubMed/NCBI
|
